Show simple item record

dc.contributor.advisorHaggarty, Stephenen_US
dc.contributor.advisorHooker, Jacoben_US
dc.contributor.advisorMazitschek, Ralphen_US
dc.contributor.advisorSzostak, Jacken_US
dc.contributor.authorRicq, Emilyen_US
dc.date.accessioned2017-07-25T14:38:04Z
dc.date.created2016-05en_US
dc.date.issued2016-05-18en_US
dc.date.submitted2016en_US
dc.identifier.citationRicq, Emily. 2016. Chemical Neurobiology of the Histone Lysine Demethylase KDM1A. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences.en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:33493305
dc.description.abstractEpigenetic mechanisms regulate gene expression and mediate interactions between genetic factors and environmental exposures. The enzymes responsible for epigenetic regulation may thus be important therapeutic targets for multifactorial neurological syndromes. KDM1A, the first histone lysine demethylase to be discovered, regulates the maturation of neurons and is inactivated by non-selective monoamine oxidase inhibitors such as the antidepressant tranylcypromine. This thesis entails the development of small-molecule tools to study KDM1A in a neurobiological context, with application towards the development of new therapeutic agents. We leveraged the chemical scaffold of tranylcypromine to generate novel KDM1A inhibitors. In chapter 2, we profile these analogs using biochemical, cellular, and in vivo assays. We show that RN1 potently inhibits KDM1A, exhibits high brain uptake, and affects the behavior of mice in a novel object recognition assay. Thermal shift assays reveal engagement of KDM1A by tranylcypromine in the brains of systemically-treated rats, suggesting that inhibition of KDM1A by non-selective antidepressants in a clinical setting warrants further examination. We sought to discover new mechanisms of KDM1A inhibition in order to gain further selectivity versus the monoamine oxidases. In chapter 3, we present outcomes of a high-throughput screen and secondary assays which reveal a predominant mode of KDM1A inhibition based on thiol-reactivity, and widespread contamination of test compounds by elemental sulfur. We show that KDM1A is inhibited by the FDA-approved drug disulfiram, and disclose two novel scaffolds for medicinal chemistry development. In chapter 4, we further profile the thiol-reactivity of KDM1A and show that catalytically-generated hydrogen peroxide negatively regulates demethylase activity. MALDI-TOF mass spectrometry indicates that hydrogen peroxide blocks labeling of cysteine 600, which we propose forms an intramolecular disulfide bond with cysteine 618. This activity-dependent regulation is unique among histone-modifying enzymes but consistent with redox sensitivity of epigenetic regulators. KDM1A may use this thiol/disulfide switch as a mechanism to sense other cellular oxidants, such as the monoamine neurotransmitter dopamine.en_US
dc.description.sponsorshipChemistry and Chemical Biologyen_US
dc.format.mimetypeapplication/pdfen_US
dc.language.isoenen_US
dash.licenseLAAen_US
dc.subjectChemistry, Biochemistryen_US
dc.titleChemical Neurobiology of the Histone Lysine Demethylase KDM1Aen_US
dc.typeThesis or Dissertationen_US
dash.depositing.authorRicq, Emilyen_US
dc.date.available2017-07-25T14:38:04Z
thesis.degree.date2016en_US
thesis.degree.grantorGraduate School of Arts & Sciencesen_US
thesis.degree.levelDoctoralen_US
thesis.degree.nameDoctor of Philosophyen_US
dc.type.materialtexten_US
thesis.degree.departmentChemistry and Chemical Biologyen_US
dash.identifier.vireohttp://etds.lib.harvard.edu/gsas/admin/view/1053en_US
dc.description.keywordsEpigenetics; flavoprotein; chemical biology; thiol/disulfideen_US
dash.author.emailemily.ricq@gmail.comen_US
dash.identifier.orcid0000-0002-5819-7956en_US
dash.contributor.affiliatedRicq, Emily


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record